Zacks' Voice of the People highlights opportunities with Salix Pharmaceuticals, Cognizant Technologies, U.S. Steel, Amylin Pharmaceuticals and Kansas City Southern - Press Releases
For Immediate Release
Chicago, IL – April 7, 2010 – Zacks highlights commentary from People and Picks Trader “MightyMo".
For more Voice of the People, visit http://at.zacks.com/?id=5851
Featured Post
Five stocks I wish were in my portfolio:
Salix Pharmaceuticals (SLXP), Cognizant Technologies (CTSH), U.S. Steel (X), Amylin Pharmaceuticals (AMLN), Kansas City Southern (KSU)
With the market at or near a near-term high and these stocks likewise, even I, who is one not afraid to purchase high climbing stocks, will hesitate to dive in.
The market is not open as I write this.
One stock is a RAILROAD
Two are BIO speculative stocks
One hits the spot and is a riddle (X)
One is a computer outsource company
I like the computer outsource company and have been trying to purchase it the last two sessions. I probably won't be able to catch it today as well. Will try though.
Out motto: (the 'gist' of it). Buying equities that have dropped in price in what appears to be 'bargains" or "cheap" is a fool's high-risk game unless you have the proper research tools or 'insider' type border line legal information about a company. Most individuals don't have access to these research vehicles. Buying stocks that have demonstrated a move is actually a conservative and low risk play (especially if you follow good money management 'cut your loss' rules.
About the Zacks Community
In 2008, Zacks Investment Research launched PeopleAndPicks.com, a stock-picking website where members of the Zacks community can test their strategies and share ideas with other members. Each user is scored on the accuracy of his or her picks, and top users are rewarded with free products from Zacks. Registration is free. To learn more about People And Picks, visit http://at.zacks.com/?id=5957
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3:1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit From the Pros by going to http://at.zacks.com/?id=5958.
Follow us on Twitter: http://twitter.com/ZacksInvestment
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Contact: Brent Billock
People & Picks Manager
Company: Zacks.com
Phone: 312-265-9307
Email: pandp@zacks.com
Visit: www.Zacks.com
The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
